ALERISLIFE INC (ALR) Fundamental Analysis & Valuation

NASDAQ:ALR • US33832D2053

Current stock price

1.32 USD
+0.01 (+0.76%)
Last:

This ALR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ALR Profitability Analysis

1.1 Basic Checks

  • In the past year ALR has reported negative net income.
  • In the past year ALR has reported a negative cash flow from operations.
ALR Yearly Net Income VS EBIT VS OCF VS FCFALR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 50M -50M -100M

1.2 Ratios

  • ALR has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALR Yearly ROA, ROE, ROICALR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 -20 -40 -60 -80 -100

1.3 Margins

  • ALR has a Gross Margin of 17.07%. This is in the lower half of the industry: ALR underperforms 67.54% of its industry peers.
  • In the last couple of years the Gross Margin of ALR has declined.
  • The Profit Margin and Operating Margin are not available for ALR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.79%
GM growth 5Y-27.35%
ALR Yearly Profit, Operating, Gross MarginsALR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ALR Health Analysis

2.1 Basic Checks

  • ALR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALR has more shares outstanding
  • ALR has a worse debt/assets ratio than last year.
ALR Yearly Shares OutstandingALR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 10M 20M 30M
ALR Yearly Total Debt VS Total AssetsALR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M 500M

2.2 Solvency

  • ALR has an Altman-Z score of 0.82. This is a bad value and indicates that ALR is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.82, ALR perfoms like the industry average, outperforming 41.23% of the companies in the same industry.
  • A Debt/Equity ratio of 0.45 indicates that ALR is not too dependend on debt financing.
  • The Debt to Equity ratio of ALR (0.45) is better than 64.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 0.82
ROIC/WACCN/A
WACC7.46%
ALR Yearly LT Debt VS Equity VS FCFALR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 100M -100M 200M

2.3 Liquidity

  • ALR has a Current Ratio of 1.58. This is a normal value and indicates that ALR is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.58, ALR is doing good in the industry, outperforming 62.28% of the companies in the same industry.
  • ALR has a Quick Ratio of 1.58. This is a normal value and indicates that ALR is financially healthy and should not expect problems in meeting its short term obligations.
  • ALR has a better Quick ratio (1.58) than 68.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
ALR Yearly Current Assets VS Current LiabilitesALR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. ALR Growth Analysis

3.1 Past

  • ALR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -141.67%.
  • ALR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.89%.
  • The Revenue has been decreasing by -7.47% on average over the past years.
EPS 1Y (TTM)-141.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.73%
Revenue 1Y (TTM)-31.89%
Revenue growth 3Y-12.4%
Revenue growth 5Y-7.47%
Sales Q2Q%-19.12%

3.2 Future

  • ALR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.52% yearly.
  • The Revenue is expected to decrease by -1.08% on average over the next years.
EPS Next Y-29.68%
EPS Next 2Y15.18%
EPS Next 3Y20.52%
EPS Next 5YN/A
Revenue Next Year-23.66%
Revenue Next 2Y-6.24%
Revenue Next 3Y-1.08%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALR Yearly Revenue VS EstimatesALR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
ALR Yearly EPS VS EstimatesALR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2020 2021 2022 2023 2024 -1 -2 -3 -4 -5

More info and screens

Find the best growth stocksShow best growing peers

1

4. ALR Valuation Analysis

4.1 Price/Earnings Ratio

  • ALR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ALR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALR Price Earnings VS Forward Price EarningsALR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALR Per share dataALR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALR's earnings are expected to grow with 20.52% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.18%
EPS Next 3Y20.52%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALR Dividend Analysis

5.1 Amount

  • ALR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ALR Fundamentals: All Metrics, Ratios and Statistics

ALERISLIFE INC

NASDAQ:ALR (3/17/2023, 8:00:00 PM)

1.32

+0.01 (+0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-07
Earnings (Next)05-01
Inst Owners89.33%
Inst Owner ChangeN/A
Ins Owners2.94%
Ins Owner Change0%
Market Cap44.18M
Revenue(TTM)707.97M
Net Income(TTM)-37.78M
Analysts45
Price Target1.53 (15.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-36.36%
Min EPS beat(2)-40.7%
Max EPS beat(2)-32.01%
EPS beat(4)0
Avg EPS beat(4)-99.82%
Min EPS beat(4)-179.03%
Max EPS beat(4)-32.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.83%
Min Revenue beat(2)-5.43%
Max Revenue beat(2)-0.24%
Revenue beat(4)0
Avg Revenue beat(4)-4.43%
Min Revenue beat(4)-7.44%
Max Revenue beat(4)-0.24%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B 0.29
P/tB 0.29
EV/EBITDA N/A
EPS(TTM)-1.16
EYN/A
EPS(NY)-0.55
Fwd EYN/A
FCF(TTM)-2.07
FCFYN/A
OCF(TTM)-1.61
OCFYN/A
SpS21.15
BVpS4.61
TBVpS4.61
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.07%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.79%
GM growth 5Y-27.35%
F-Score2
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 122.36%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 0.82
F-Score2
WACC7.46%
ROIC/WACCN/A
Cap/Depr(3y)158.12%
Cap/Depr(5y)159.36%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-141.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.73%
EPS Next Y-29.68%
EPS Next 2Y15.18%
EPS Next 3Y20.52%
EPS Next 5YN/A
Revenue 1Y (TTM)-31.89%
Revenue growth 3Y-12.4%
Revenue growth 5Y-7.47%
Sales Q2Q%-19.12%
Revenue Next Year-23.66%
Revenue Next 2Y-6.24%
Revenue Next 3Y-1.08%
Revenue Next 5YN/A
EBIT growth 1Y-736.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.21%
EBIT Next 3Y35.15%
EBIT Next 5YN/A
FCF growth 1Y-137.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-114.74%
OCF growth 3YN/A
OCF growth 5YN/A

ALERISLIFE INC / ALR Fundamental Analysis FAQ

What is the fundamental rating for ALR stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALR.


Can you provide the valuation status for ALERISLIFE INC?

ChartMill assigns a valuation rating of 3 / 10 to ALERISLIFE INC (ALR). This can be considered as Overvalued.


How profitable is ALERISLIFE INC (ALR) stock?

ALERISLIFE INC (ALR) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for ALR stock?

The Earnings per Share (EPS) of ALERISLIFE INC (ALR) is expected to decline by -29.68% in the next year.